GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Cyclopharm CYC.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.46

0.00%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Cyclopharm — daily ASX:CYC

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Cyclopharm on TradingView ↗
Market value
A$46.8m
Last close × shares
Volume
68.6k
Shares, 9 Nov 2026

About Cyclopharm

Its shares trade on ASX under the ticker CYC.AX. It has been listed since 18 January 2007. In the fiscal year to 31 December 2025, it reported revenue of A$32.3m and a net loss of A$17.2m. At that date it held total assets of A$46.1m and shareholders' equity of A$27.1m.

Cyclopharm Ltd. is a radiopharmaceutical company, which engages in the diagnostic imaging in lung health. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-01-18. The firm operates in two business segments: Technegas segment and Molecular imaging segment. The Technegas segment is a supplier of diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. The Molecular Imaging segment produces radiopharmaceuticals used by physicians in the detection of cancer, neurological disorders and cardiac diseases. The firm offers Technegas for lung imaging, and Molecular Imaging/Positron Emission Tomography radiopharmaceuticals, which are used in cancer, brain and cardiac imaging. The firm formed a joint venture with Alfred Health Solutions and Macquarie University Hospital to provide various imaging services on-site at the hospital. The firm's Ultralute is a device that extends the useful life of Molybdenum-99 (Mo-99) generators.

Figures and description from our data supplier, not checked against the company's own report.

More about Cyclopharm →

Latest on Cyclopharm

Our reporting

We have not reported on Cyclopharm yet.

Next results

24 Feb 2027

Due on 24 Feb 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Cyclopharm's ticker?

Cyclopharm trades as CYC.AX on ASX, under ISIN AU000000CYC5.

What was Cyclopharm's last closing price?

0.46 on 9 Nov 2026. The figure is in AUD and is never converted.

When does Cyclopharm next report results?

Results are expected on 24 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.